Aktive Positionen von Stephen M. Notestine
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sequoia Sciences, Inc.
 Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Sequoia Sciences, Inc. engages in the development of new medicines for the treatment of bacterial infections and cancers. The firm's development programs consist of small molecules targeting bacterial infections and cancers, and vaccines for the treatment and prevention of recurrent urinary tract infections. The company was founded by Gary R. Eldridge, Jr. in 1999 and is headquartered in St. Louis, MO. | Direktor/Vorstandsmitglied | 01.01.1999 | - |
| Quadrant Properties LLC | Gründer | 29.09.2009 | - |
| Corporate Officer/Principal | 29.09.2009 | - | |
Sequoia Vaccines, Inc.
 Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Direktor/Vorstandsmitglied | 01.01.2021 | - |
| Independent Dir/Board Member | 01.01.2021 | - | |
| Roman Catholic Foundation of Eastern Missouri | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Stephen M. Notestine
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director/Board Member | 3 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Sequoia Sciences, Inc.
Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Sequoia Sciences, Inc. engages in the development of new medicines for the treatment of bacterial infections and cancers. The firm's development programs consist of small molecules targeting bacterial infections and cancers, and vaccines for the treatment and prevention of recurrent urinary tract infections. The company was founded by Gary R. Eldridge, Jr. in 1999 and is headquartered in St. Louis, MO. | Health Technology |
| Quadrant Properties LLC | |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Health Technology |
| Roman Catholic Foundation of Eastern Missouri |
- Börse
- Insiders
- Stephen M. Notestine
- Erfahrung
